Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2’084 DKK | -1.98% | +3.73% | -3.29% |
18.03. | Genmab schließt Aktienrückkaufprogramm ab | MT |
15.03. | Genmab kauft bis zu 511 Millionen $ Aktien zurück | MT |
ETFs investiert in Genmab A/S
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
3,64% | 196 M€ | +12.16% | ||
1,28% | 49 M€ | +7.05% | ||
1,01% | 80 M€ | +3.25% | ||
0,75% | 18 M€ | +7.01% | - | |
0,56% | 673 M€ | +9.05% | ||
0,49% | 88 M€ | +10.37% | - | |
0,45% | 25 M€ | +4.54% | - | |
0,33% | 6 M€ | -.--% | - | |
0,33% | 4 M€ | -.--% | - | |
0,32% | 35 M€ | +3.97% | - | |
0,31% | 6 M€ | -.--% | ||
0,29% | 2 M€ | +9.19% | - | |
0,29% | 2 M€ | -.--% | - | |
0,24% | 29 M€ | +8.37% | - | |
0,20% | 7 M€ | +4.41% | - | |
0,19% | 21 M€ | +2.53% | - | |
0,14% | 3 859 M€ | +7.97% | ||
0,14% | 469 M€ | -2.05% | ||
0,14% | 10 M€ | -3.35% | - | |
0,09% | 276 M€ | +11.40% | - | |
0,08% | 268 M€ | -.--% | - | |
0,08% | 193 M€ | +9.76% | - | |
0,08% | 460 M€ | +12.25% | ||
0,07% | 7 M€ | +2.89% | - | |
0,06% | 0 M€ | 0.00% | - | |
0,04% | 274 M€ | +15.39% | ||
0,04% | 206 M€ | -.--% | ||
0,04% | 1 166 M€ | +0.26% | - | |
0,04% | 607 M€ | +0.05% | - | |
0,04% | 23 M€ | -.--% | - | |
0,04% | 786 M€ | -.--% |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
-3.29% | 19.71 Mrd. | |
+2.59% | 108 Mrd. | |
+9.67% | 104 Mrd. | |
+6.58% | 23.66 Mrd. | |
-12.40% | 22.1 Mrd. | |
-35.36% | 18.2 Mrd. | |
-13.15% | 16.19 Mrd. | |
+4.32% | 13.72 Mrd. | |
+34.01% | 12.22 Mrd. | |
-6.23% | 10.36 Mrd. |
- Börse
- Aktien
- Aktie Genmab A/S - Nasdaq Copenhagen
- ETFs Genmab A/S